Group 1 - The core point of the article is that Guofu Quantum (00290) has resumed trading with its stock price surging over 8% following the announcement of a significant share sale [1] - Guofu Quantum's largest shareholder, Liu Zhiwei, and shareholder Wang Tao will sell a total of 1.848 billion shares, representing approximately 20.31% of the company's issued share capital, to FINAL TOUCH LTD., a wholly-owned subsidiary of Huajian Medical, for HKD 3.142 billion [1] - After the transaction, Liu Zhiwei will no longer be the largest shareholder, and the buyer will become the new largest shareholder [1] Group 2 - Huajian Medical announced plans to collaborate with Guofu Quantum to build a comprehensive strategic synergy around "on-chain finance," focusing on the innovation and implementation of digital financial infrastructure [1] - The two companies will integrate technology, licenses, assets, and channel resources to create an efficient, compliant, and open platform for the issuance, trading, and management of on-chain assets, aiming to accelerate the digitization, fragmentation, and cross-border flow of traditional financial assets [1]

Group 1 - The company Huajian Medical (01931) announced a proposed acquisition of approximately 1.848 billion shares of Guofu Quantum (00290), representing 20.31% of the target company's total issued share capital, for about HKD 3.142 billion, to be paid through the issuance of shares at an issue price of HKD 9.69 per share [1] - The target group primarily engages in investment banking, securities brokerage, asset management, margin financing, lending, debt investment, equity investment, and immigration consulting, while actively investing in the quantum technology industry [1] - This acquisition is a significant step for the company in advancing its RWA exchange strategy and achieving ecological synergy, highlighting its deep industrial significance and capital value [1] Group 2 - Upon completion of the acquisition, Huajian Medical will collaborate with Guofu Quantum to build a comprehensive strategic synergy around "on-chain finance," promoting innovation and implementation of digital financial infrastructure [1] - The two companies will integrate technology, licenses, assets, and channel resources to create an efficient, compliant, and open platform for on-chain asset issuance, trading, and management, accelerating the digitalization, fragmentation, and cross-border flow of traditional financial assets [1]

Group 1 - The core point of the article is that Huajian Medical (01931) plans to acquire approximately 1.848 billion shares of Guofu Quantum (00290), representing 20.31% of the target company's total issued share capital, for about HKD 3.142 billion, with the payment to be made through the issuance of shares at a price of HKD 9.69 per share [1] - The target group primarily engages in investment banking, securities brokerage, asset management, margin financing, lending, debt investment, equity investment, and immigration consulting [1] - The acquisition is a significant step for the group to advance its RWA exchange strategy and achieve ecological synergy, highlighting its profound industrial significance and capital value [1] Group 2 - After the acquisition, Huajian Medical will deepen strategic collaboration with Guofu Quantum to build a comprehensive "on-chain finance" ecosystem, promoting innovation and implementation of digital financial infrastructure [1] - Both companies will integrate technology, licenses, assets, and channel resources to create an efficient, compliant, and open platform for on-chain asset issuance, trading, and management, accelerating the digitalization, fragmentation, and cross-border flow of traditional financial assets [1]